<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: <z:mp ids='MP_0001845'>Inflammation</z:mp> is an important factor in the development of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, and <z:hpo ids='HP_0001397'>fatty liver</z:hpo> disease </plain></SENT>
<SENT sid="1" pm="."><plain>As a member of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor receptor superfamily (TNFRSF9) expressed on immune cells, 4-1BB/CD137 provides a bidirectional inflammatory signal through binding to its ligand 4-1BBL </plain></SENT>
<SENT sid="2" pm="."><plain>Both 4-1BB and 4-1BBL have been shown to play an important role in the pathogenesis of various <z:e sem="disease" ids="C1290884" disease_type="Disease or Syndrome" abbrv="">inflammatory diseases</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>RESEARCH DESIGN AND METHODS: Eight-week-old male 4-1BB-deficient and <z:mp ids='MP_0002169'>wild-type</z:mp> (WT) mice were fed a high-fat diet (HFD) or a regular diet for 9 weeks </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: We demonstrate that 4-1BB deficiency protects against HFD-induced <z:hpo ids='HP_0001513'>obesity</z:hpo>, <z:hpo ids='HP_0000833'>glucose intolerance</z:hpo>, and <z:hpo ids='HP_0001397'>fatty liver</z:hpo> disease </plain></SENT>
<SENT sid="5" pm="."><plain>The 4-1BB-deficient mice fed an HFD showed less body <z:mp ids='MP_0005456'>weight gain</z:mp>, <z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">adiposity</z:e>, adipose infiltration of macrophages/T cells, and tissue levels of inflammatory cytokines (e.g., TNF-Î±, interleukin-6, and monocyte chemoattractant protein-1 [<z:chebi fb="17" ids="50099">MCP</z:chebi>-1]) compared with HFD-fed control mice </plain></SENT>
<SENT sid="6" pm="."><plain>HFD-induced <z:hpo ids='HP_0000833'>glucose intolerance</z:hpo>/<z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and <z:hpo ids='HP_0001397'>fatty liver</z:hpo> were also markedly attenuated in the 4-1BB-deficient mice </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: These findings suggest that 4-1BB and 4-1BBL may be useful therapeutic targets for combating <z:hpo ids='HP_0001513'>obesity</z:hpo>-induced <z:mp ids='MP_0001845'>inflammation</z:mp> and <z:e sem="disease" ids="C0025517" disease_type="Disease or Syndrome" abbrv="">metabolic disorders</z:e> </plain></SENT>
</text></document>